Pricing Log in Create free account
Friday 23 October 2026 Export HR’s income statement to Excel — free account

Healthcare Realty Trust Incorporated

HR Real Estate Reit Healthcare Facilities

Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024. In the quarter to June 2026, revenue fell 5.26%, EPS grew 71.1%, free cash flow fell 28.8% and total debt rose 1.48%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

17.89 0.04 −0.22%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
−176×
Dividend yield
5.37%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.18
Total sells 0.93
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — 2 — — — — — — —
Sell — — — — — — — 1 — — 1 —
Insider Ownership 0.72%

Capital & Financial Ratios $m

Market Cap 6,140.00
Revenue 1,144.91
Net Income (87.89)
Free Cash Flow 1,413.01
Net Debt 55.11
Current Ratio 0.00
Debt/Equity 0.02
P/E ratio 0.00
Fwd P/E (176.00) (negative: loss-making)
P/S ratio 5.35
P/B ratio 1.43
Past 5Y EPS Growth —
This Y EPS Growth 85.06% (at or above 15%: strong)
Next Y EPS Growth 169.63% (at or above 15%: strong)
Next Y revenue growth (4.87%) (below 0%: weak)
Next 5Y EPS Growth 65.17% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 5.4×, against a ten-year median of 12.6×; over the ten years it ranged from 3.9× in 2024 to 19.8× in 2021.
P/S against its own 10 years 25.42%
10-year low 10-year high
P/B against its own 10 years 41.54%
10-year low 10-year high
EV/Sales against its own 10 years 25.50%
10-year low 10-year high
EV/FCF against its own 10 years 21.12%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate 0.96
Annual Dividend Yield 5.37%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.96
0.24
0.24
0.24
2025 1.10
0.31
0.31
0.24
0.24
2024 1.24
0.31
0.31
0.31
0.31
2023 1.24
0.31
0.31
0.31
0.31
2022 2.04
0.33
0.31
0.33
0.31
0.33
0.03
4.82
0.11
0.31
2021 2.49
0.32
0.30
0.32
0.30
0.32
0.30
0.33
0.30
2020 2.15
0.30
0.32
0.30
0.32
0.30
0.32
0.30
2019 2.45
0.30
0.31
0.30
0.31
0.30
0.32
0.30
0.32
2018 2.43
0.30
0.31
0.30
0.31
0.30
0.31
0.30
0.31
2017 2.41
0.30
0.30
0.30
0.30
0.30
0.31
0.30
0.31
2016 2.39
0.30
0.30
0.30
0.30
0.30
0.30
0.30
0.30
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 26 69 26 19
Receivables — — — —
Inventory — — — —
Other — — — —
26 69 26 19
2023 2024 2025 Q'26
Payables 212 223 211 160
ST’ Debt — — — —
Other — — — —
5,207 4,885 4,122 4,327

Compound Annual Growth %

10y 5y 3y
Sales 11.32% 18.76% 8.17%
Cash Flow 9.11% (0.56%) 18.78%
Earnings 0.00% 0.00% 0.00%
Book Value 12.75% 7.63% (15.26%)

Revenue $m

Mar Jun Sep Dec Year
’26 279 282 — — —
’25 299 298 298 286 1,181
’24 327 316 315 310 1,268
’23 333 338 342 330 1,344
’22 143 145 306 338 933
’21 191 131 137 75 535
’20 186 179 187 (52) 500
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 53 142 — — —
’25 48 163 114 132 457
’24 76 168 119 138 502
’23 69 185 118 127 500
’22 44 70 13 146 273
’21 65 40 65 62 233
’20 75 107 87 200 470
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 80 152 — — —
’25 67 214 437 744 1,462
’24 76 471 539 636 1,723
’23 188 188 315 461 1,152
’22 7 (72) 685 451 1,071
’21 36 59 (64) 19 51
’20 58 45 114 (139) 78
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.00 (0.13) — — —
’25 (0.13) (0.45) (0.17) 0.04 (0.71)
’24 (0.82) (0.39) (0.26) (0.31) (1.81)
’23 (0.23) (0.22) (0.18) (0.11) (0.74)
’22 0.28 0.04 0.08 (0.09) 0.15
’21 0.10 0.17 (0.01) 0.07 0.44
’20 0.08 0.06 (0.03) 0.43 0.54
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Price, $
Price, $ Low 26.66 29.67 26.09 27.43 24.10 28.00 18.16 13.86 12.77 14.09 (6.8%) ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
High 36.60 36.25 32.22 34.89 37.97 33.77 32.38 22.36 18.90 18.97 (7.0%) ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
People
People Employees 214 270 282 303 333 357 583 584 550 539 +10.8% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
Revenue/emp, $m 2.15 2.27 2.47 2.28 1.50 1.50 1.60 2.30 2.31 2.19 +0.2% ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
Income, $m
Income, $m Revenue 461 614 696 692 500 535 933 1,344 1,268 1,181 +11.0% 1,123 1,156 1,218 +1.0%
Gross margin, % 68.81 68.71 68.32 69.44 60.67 60.31 63.11 62.76 62.67 61.96 (6.9) pt
EBT 47 66 218 31 72 67 41 (282) (664) (249) n/m
EBT margin, % 10.27 10.68 31.25 4.44 14.45 12.46 4.36 (20.99) (52.35) (21.13) (31.4) pt
Net income 47 66 218 31 72 67 41 (282) (664) (249) n/m
Depreciation 175 239 271 281 193 202 458 743 947 587 +14.4%
Per share, $
Per share, $ Revenue 3.37 3.39 3.38 3.36 3.73 3.75 3.70 3.55 3.47 3.37 0.0%
Earnings 0.34 0.35 1.04 0.15 0.54 0.45 0.15 (0.74) (1.81) (0.71) n/m
Cash flow 1.49 1.70 1.64 1.65 3.51 1.63 1.08 1.32 1.37 1.31 (1.5%)
Capex (4.45) (13.08) 1.02 (3.11) (2.93) (1.27) 3.16 1.72 3.34 2.87 n/m
Free cash flow (2.96) (11.38) 2.66 (1.46) 0.58 0.36 4.25 3.04 4.71 4.18 n/m
Book value 13.03 18.58 16.18 16.68 24.15 15.32 30.43 18.26 14.50 13.36 +0.3%
Shares, m 137 181 206 206 134 143 252 379 366 350 +11.0%
Valuation, ×
Valuation, × P/E 86.14 91.51 27.88 222.47 55.44 97.17 62.74 0.00 0.00 0.00 64.3
P/S 8.94 9.45 8.42 9.92 7.93 8.44 5.32 4.89 4.89 5.02 7.3
P/B 2.31 1.72 1.76 2.00 1.23 2.07 0.65 0.95 1.17 1.27 1.5
EV/Sales 12.72 13.78 11.87 13.84 13.76 8.46 5.34 4.93 4.89 5.06 9.5
EV/FCF (14.49) (4.11) 15.11 (31.97) 88.52 88.84 4.64 5.75 3.60 4.09 16.0
Cash, $m
Cash, $m Operating cash flow 204 308 337 340 470 233 273 500 502 457 +9.4%
Capex (608) (2,368) 210 (640) (392) (182) 799 652 1,221 1,005 n/m
Free cash flow (405) (2,060) 547 (300) 78 51 1,071 1,152 1,723 1,462 n/m
Balance, $m
Balance, $m Working capital 93 159 (52) 103 170 (1,874) (5,535) (5,181) (4,816) (4,096) n/m
Total debt 1,769 2,781 2,541 2,750 3,027 23 73 75 72 73 (29.8%)
Net debt 1,744 2,662 2,408 2,712 2,908 9 12 49 3 47 (33.1%)
Shareholders’ equity 1,780 3,363 3,335 3,431 3,235 2,185 7,680 6,919 5,301 4,673 +11.3%
Returns, %
Returns, % ROA 1.33 1.25 3.38 0.47 1.08 1.21 0.45 (2.10) (5.62) (2.48) (3.8) pt
ROIC 1.81 1.28 1.64 1.49 0.81 2.33 (0.19) 0.49 0.39 1.23 (0.6) pt
ROE 2.88 2.49 6.37 0.89 2.17 2.46 0.83 (3.81) (10.71) (4.93) (7.8) pt
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.40 Actual 0.41

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.40 0.41 Beat by 0.01
Q4 FY25 0.40 0.40 Met by 0.00
Q1 FY26 0.39 0.41 Beat by 0.02
Q2 FY26 0.40 0.41 Beat by 0.01
Q3 FY26 0.41 — Reports 29 October 2026

Charts ten years each

Healthcare Realty Trust Incorporated vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
OHI Omega Healthcare Investors, Inc. $14.0B 16.3× 18.5× +16.19% (above 0%: growing) +163.04% (above 0%: growing) +710.56% (above 0%: growing) 100.00% 57.45% Compare
DOC Healthpeak Properties, Inc. $13.7B 55.0× 44.0× +11.12% (above 0%: growing) +60.00% (above 0%: growing) −30.47% (below 0%: shrinking) 56.83% 16.18% Compare
AHR American Healthcare REIT, Inc. $11.7B 78.0× 86.0× +24.29% (above 0%: growing) +166.67% (above 0%: growing) +9.53% (above 0%: growing) 20.35% 6.29% Compare
CTRE CareTrust REIT, Inc. $8.7B 23.0× 23.4× +43.46% (above 0%: growing) +5.56% (above 0%: growing) +88.99% (above 0%: growing) 98.66% 67.53% Compare
HR Healthcare Realty Trust Incorporated $6.1B — (loss-making) — (loss-making) −5.26% (below 0%: shrinking) n/m −28.80% (below 0%: shrinking) 64.88% 13.83%
SBRA Sabra Healthcare REIT, Inc. $5.0B 75.3× 43.3× +24.70% (above 0%: growing) n/m −666.09% (below 0%: shrinking) 100.00% (13.59%) Compare
NHI National Health Investors, Inc. $3.3B 19.4× 16.3× +33.81% (above 0%: growing) +45.57% (above 0%: growing) +2,585.45% (above 0%: growing) 72.18% 41.09% Compare
LTC LTC Properties, Inc. $2.3B 16.0× 5.4× +64.11% (above 0%: growing) +72.73% (above 0%: growing) −213.92% (below 0%: shrinking) 100.00% 31.24% Compare
DHC Diversified Healthcare Trust $1.9B — (loss-making) 8.4× −4.53% (below 0%: shrinking) n/m −93.96% (below 0%: shrinking) 23.11% (0.14%) Compare
Median of peers $6.8B 23.0× 21.0× +24.50% +66.37% −10.47% 85.42% 23.71%

All 17 Reit Healthcare Facilities stocks →

Healthcare Realty Trust Incorporated (HR) key facts

  • Concern: Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024.
  • Concern: Healthcare Realty Trust Incorporated reported a net loss of $249.5 million, or a loss of $0.71 per share, for fiscal 2025.
  • Healthcare Realty Trust Incorporated (HR) is a Reit Healthcare Facilities company in the Real Estate sector, listed on the New York Stock Exchange.
  • As of October 23, 2026, HR traded at $17.89, a market capitalization of $6.1 billion.
  • Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 5.3× sales.
  • Healthcare Realty Trust Incorporated pays an annual dividend of $0.96 per share, a yield of 5.37%.
  • Return on equity was −4.93% and debt-to-equity 0.02.
  • Its Piotroski F-score is 5 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Healthcare Realty Trust Incorporated (HR) Latest News

12 Oct

Impact 4 ·

9 Oct

Impact 4 ·
Impact 4 ·

7 Aug

Impact 4 · transcript

31 Jul

Impact 4 · transcript
Impact 4 ·
Impact 4 ·

30 Jul

Impact 4 ·

5 May

Impact 4 ·

4 May

Impact 4 ·
Impact 4 ·

2 May

Impact 4 ·

1 May

Impact 4 ·
Impact 4 · transcript
Impact 4 ·

30 Apr

Impact 4 ·

17 Feb

Impact 4 ·

13 Feb

Impact 4 · transcript
Impact 4 · transcript
Impact 4 · transcript

12 Feb

Impact 4 ·

6 Feb

Impact 4 ·

16 Dec

Impact 4 ·

31 Oct

Impact 4 · transcript

30 Oct

Impact 4 ·
Impact 4 ·

8 Oct

Impact 4 ·

11 Sep

Impact 4 ·

2 Aug

Impact 4 · transcript

7 May

Impact 4 · transcript
stockrow.com/HR · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com